Aspiriant LLC’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Buy |
3,866
+530
| +16% | +$42.6K | 0.01% | 246 |
|
|
2025
Q1 | $268K | Buy |
3,336
+115
| +4% | +$9.23K | 0.01% | 249 |
|
|
2024
Q4 | $264K | Buy |
3,221
+3
| +0.1% | +$246 | 0.01% | 248 |
|
|
2024
Q3 | $265K | Buy |
3,218
+17
| +0.5% | +$1.4K | 0.01% | 248 |
|
|
2024
Q2 | $225K | Sell |
3,201
-1,095
| -25% | -$76.9K | 0.01% | 261 |
|
|
2024
Q1 | $318K | Buy |
4,296
+88
| +2% | +$6.52K | 0.01% | 237 |
|
|
2023
Q4 | $278K | Buy |
4,208
+95
| +2% | +$6.28K | 0.01% | 253 |
|
|
2023
Q3 | $259K | Buy |
4,113
+297
| +8% | +$18.7K | 0.01% | 241 |
|
|
2023
Q2 | $216K | Sell |
3,816
-26
| -0.7% | -$1.47K | 0.01% | 267 |
|
|
2023
Q1 | $223K | Buy |
3,842
+98
| +3% | +$5.68K | 0.01% | 259 |
|
|
2022
Q4 | $271K | Buy |
3,744
+243
| +7% | +$17.6K | 0.01% | 225 |
|
|
2022
Q3 | $213K | Buy |
3,501
+113
| +3% | +$6.88K | 0.01% | 243 |
|
|
2022
Q2 | $213K | Buy |
3,388
+42
| +1% | +$2.64K | 0.01% | 258 |
|
|
2022
Q1 | $235K | Buy |
+3,346
| New | +$235K | 0.01% | 251 |
|
|
2018
Q2 | – | Sell |
-4,600
| Closed | -$211K | – | 257 |
|
|
2018
Q1 | $211K | Buy |
+4,600
| New | +$211K | 0.02% | 226 |
|